346 related articles for article (PubMed ID: 8782082)
21. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons.
Olcese J; McArdle CA; Middendorff R; Greenland K
J Neuroendocrinol; 1997 Dec; 9(12):937-43. PubMed ID: 9468019
[TBL] [Abstract][Full Text] [Related]
24. VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor.
Vertongen P; Camby I; Darro F; Kiss R; Robberecht P
Neuropeptides; 1996 Oct; 30(5):491-6. PubMed ID: 8923513
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
[TBL] [Abstract][Full Text] [Related]
26. Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.
Oka H; Jin L; Reubi JC; Qian X; Scheithauer BW; Fujii K; Kameya T; Lloyd RV
Am J Pathol; 1998 Dec; 153(6):1787-96. PubMed ID: 9846969
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates growth hormone release from GH3 cells through type II PACAP receptor.
Murakami Y; Koshimura K; Yamauchi K; Nishiki M; Tanaka J; Furuya H; Miyake T; Kato Y
Regul Pept; 1995 Mar; 56(1):35-40. PubMed ID: 7770631
[TBL] [Abstract][Full Text] [Related]
28. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
D'Agata V; Cavallaro S; Stivala F; Canonico PL
Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
[TBL] [Abstract][Full Text] [Related]
29. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors.
Gourlet P; Vandermeers A; Vandermeers-Piret MC; Rathé J; De Neef P; Robberecht P
Eur J Pharmacol; 1995 Dec; 287(1):7-11. PubMed ID: 8666028
[TBL] [Abstract][Full Text] [Related]
30. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.
Braas KM; May V; Harakall SA; Hardwick JC; Parsons RL
J Neurosci; 1998 Dec; 18(23):9766-79. PubMed ID: 9822736
[TBL] [Abstract][Full Text] [Related]
33. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.
Van Rampelbergh J; Poloczek P; Françoys I; Delporte C; Winand J; Robberecht P; Waelbroeck M
Biochim Biophys Acta; 1997 Jun; 1357(2):249-55. PubMed ID: 9223629
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.
Gourlet P; Vandermeers-Piret MC; Rathé J; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
Eur J Pharmacol; 1998 May; 348(1):95-9. PubMed ID: 9650836
[TBL] [Abstract][Full Text] [Related]
35. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
Sano H; Miyata A; Horio T; Nishikimi T; Matsuo H; Kangawa K
Regul Pept; 2002 Nov; 109(1-3):107-13. PubMed ID: 12409222
[TBL] [Abstract][Full Text] [Related]
36. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
37. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23.
Vertongen P; Ciccarelli E; Woussen-Colle MC; De Neef P; Robberecht P; Cauvin A
Endocrinology; 1994 Oct; 135(4):1537-42. PubMed ID: 7925114
[TBL] [Abstract][Full Text] [Related]
39. Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas.
Robberecht P; Vertongen P; Velkeniers B; de Neef P; Vergani P; Raftopoulos C; Brotchi J; Hooghe-Peters EL; Christophe J
J Clin Endocrinol Metab; 1993 Nov; 77(5):1235-9. PubMed ID: 8077316
[TBL] [Abstract][Full Text] [Related]
40. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
